Immediate type hypersensitivity after injection of nadroparin (Fraxiparin).
Bekkenk
Marcel W
MW
Department of Dermatology BI-Q, Leiden University Medical Centre, The Netherlands.
van Zuuren
Esther J
EJ
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D003429:Cross Reactions; D017985:Dalteparin / Q000009:adverse effects; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D017984:Enoxaparin / Q000009:adverse effects; D005165:Factor V / Q000235:genetics; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D017762:Nadroparin / Q000009:adverse effects* / Q000627:therapeutic use; D017354:Point Mutation
D000925:Anticoagulants; D017984:Enoxaparin; D017762:Nadroparin; C095381:factor V Leiden; D005165:Factor V; D017985:Dalteparin